BRIEF-Adverum Biotechnologies Presents Anatomical Improvements In Intraretinal And Subretinal Fluid After A Single IVT Injection Of IXO-VEC

Reuters
01 Oct 2022

Sept 30 (Reuters) - Adverum Biotechnologies Inc

:

* ADVERUM BIOTECHNOLOGIES PRESENTS ANATOMICAL IMPROVEMENTS IN INTRARETINAL AND SUBRETINAL FLUID AFTER A SINGLE IVT INJECTION OF IXO-VEC (ADVM-022) IN THE OPTIC STUDY IN WET AMD

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10